NUVB
USDNuvation Bio Inc. Class A Common Stock
$4.830-0.320 (-6.214%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$5.150
最高
$5.190
最低
$3.920
交易量
6.20M
公司基本面
市值
1.7B
行業
生物科技
國家
United States
交易統計
平均交易量
7.11M
交易所
NYQ
貨幣
USD
52週範圍
最低 $1.54當前 $4.830最高 $5.55
相關新聞
Analyst Upgrades
RBC Capital Maintains Outperform on Nuvation Bio, Raises Price Target to $8
RBC Capital analyst Leonid Timashev maintains Nuvation Bio with a Outperform and raises the price target from $7 to $8.
查看更多
BusinessWire
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Successfully started 204 patients on IBTROZI™ (taletrectinib) in the third quarter of 2025 Updated data continue to show IBTROZI's unprecedented durability in TKI-naïve, advanced ROS1-positive (ROS1+) non-small
查看更多
BusinessWire
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio Inc. (NYSE:NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of
查看更多
